[PDF] Top 20 Evaluation of markers of outcome in real-world treatment of diabetic macular edema

... The average thickness of the central 1 mm field of the 6 mm OCT-modified ETDRS grid was used to evaluate changes in the CRT over time. The presumed fovea was considered as the region with the photoreceptor layer alone ... See full document

... in treatment patterns for DME occurred in Taiwanese hospital ophthalmology clinics after anti-VEGF agents became ...laser treatment declined. This study also showed that, in the real-world ... See full document

... SDM treatment was repeated at 3–4-month intervals if residual leakage was ...eye. Evaluation of the results of treatment was done using fluorescein angiography and optical coherence tomography ... See full document

... Several real-life studies have shown similar results regarding the number of retreatments during the fi rst year and a mean duration between retreatment ...additional treatment during the follow-up ... See full document

... clinical outcome data, a lack of follow-up, and a limited number of ...fast real-time image processing, which may result in ...manual treatment as a fallback in case the electronic systems do not ... See full document

... After a 6-month observation period, 6 patients were diagnosed with DME of a mostly tractional character. In these patients only a minimal effect was observed after IVTA, so pars plana (PP) vitrectomies were performed, ... See full document

... All eyes in group I received an injection of 2 mg/0.05 mL aflibercept (Eylea; Regeneron Pharmaceuticals, NY, USA) and those in group II received an injection of 0.5 mg/0.1 mL ranibi- zumab (Lucentis; Genentech, USA, ... See full document

... Our outcome measures were noted by best corrected visual acuity (BCVA), efficacy of laser treatment, duration of the laser treatment, and pain ...laser treatment was measured by 1) a decrease ... See full document

... Abstract: Diabetic macular edema (DME) is a potentially sight-threatening disease that predominantly affects patients with type 2 ...the diabetic eye, there is an inflammatory pathway that ... See full document

... Three fluorinated synthetic corticosteroids that lack miner- alocorticoid activity – triamcinolone acetonide, dexametha- sone phosphate, and fluocinolone acetonide – are currently used for the treatment of DME. ... See full document

... While comparing the studies of FAc devices head-to-head is complicated because of differences in their inclusion/ exclusion criteria, retreatment protocols, and follow-up time, both FAc devices appear to have similar ... See full document

... at macular area and complications macular edema, ...haemorrhage. Macular edema treated with macular grid laser in selective ... See full document

... each treatment strategy [24]. The incremental differences between treatment arms for each measure were determined over a lifetime horizon and the comparison was captured by the incre- mental cost per ... See full document

... Given the differences in patient populations, efficacy endpoints, and reporting of adverse events, it is not pos- sible to compare directly the findings of the dexamethasone implant trials with those of the intravitreal ... See full document

... Abstract: Diabetic macular edema is the major cause of visual acuity impairment in diabetic ...of diabetic macular edema by mediating vascular permeability and ... See full document

... glucocorticoid treatment of eye dis- eases, including DME has been in use clinically for more than 50 years ...the treatment of a variety of eye inflammatory diseases ...of macular edema ... See full document

... Diabetic macular edema (DME), is one of the most common causes of visual impairment in the diabetic patients ...of macular edema in patients with type 2 diabetes was up to 14%, ... See full document

... the treatment of noninfectious uveitis, some retrospective studies reported the use of IVT dexamethasone implants for the treatment of persistent ME secondary to infectious ... See full document

... have been due to an infected intravenous cannula. Another participant developed cellulitis of the leg whilst undergoing study treatment. This participant, however, had a preexisting history of cellulitis. One ... See full document

... of diabetic macular ...greater macular ischemia grade was independently predictive for progression, and diabetic macular ischemia progression itself was predictive of the loss of visual ... See full document